The New York Times reports that Saul Katz, who along with Fred Wilpon own around a 2/3 interest in the New York Mets, wants to sell his ownership stake.
The problem — if he sells his share, that likely deprives Fred Wilpon of his control of the team, because Wilpon doesn’t independently own 50%+ of the team. He runs it now in a partnership with Katz, who has always left baseball operations to Wilpon. If Katz were to structure the sale of his stake in such a way to prevent anyone else from having a share as large as Wilpn’s — say to separate buyers — he’d get way less than what the shares are actually worth given the lack of any team control offered to the buyers.
So, if Wilpon is to keep control of the team he’d have to buy out Katz himself, which is unlikely given the kinds of cashflow problems Wilpon has. Or I suppose he could try to get Katz to agree to take a fraction of what his large interest might go for in breaking it up among multiple buyers. For what it’s worth, Katz and Wilpon are brothers-in-law and business partners outside of the Mets, so I suppose anything is possible.
My guess: this is Katz making some noise and starting what may be a long process of getting out from under the Mets, not the harbinger of anything imminent given Wilpon’s desire to give the team to his son Jeff and given the logistical problems in place.
But, hey, if it allows Mets fans to at least begin to imagine what it’d be like for their team to be owned by people who actually have money to spend on this team I suppose it’s better than nothing.
To the surprise of, well, very few, the Mariners didn’t make the cut for the postseason this year. While they threw their hats in the ring for a wild card berth, their pitching staff just couldn’t stay healthy, from the handful of pitchers who contracted season-ending injuries in spring training to Felix Hernandez‘s shoulder bursitis to structural damage in Hisashi Iwakuma‘s right shoulder. Left-hander James Paxton missed 79 days with a lingering head cold, strained left forearm and pectoral strain. Heading into the 2018 season, the lefty told MLB.com’s Greg Johns that he plans to “nerd out big-time” in order to prepare for a healthy, consistent run with the club.
So far, Johns reports, that entails a new diet and workout program, hot yoga sessions and blood testing. “I just think there’s more I can do,” Paxton said. “I haven’t done the blood testing before. Finding out if there’s something I don’t know about myself. It’s just about learning and trying to find what works for me.”
When healthy, the 28-year-old southpaw was lights-out for the Mariners. He helped stabilize the front end of the rotation with a 12-5 record in 24 starts and supplemented his efforts with a 2.98 ERA, 2.4 BB/9 and 10.3 SO/9 through 136 innings. Despite taking multiple trips to the disabled list, he built up 4.6 fWAR — the most wins above replacement he’s compiled in any season of his career to date. Had he not been felled by a pectoral injury in mid-August — one that came with a five-week trip to the disabled list — the club might have been been able to make a bigger push for the playoffs.
Of course, even if Paxton manages to stay healthy next season, the Mariners still have the rest of the rotation to worry about. They cycled through 17 starters in 2017 and tied the 2014 Rangers with 40 total pitchers over the course of the season. Per GM Jerry Dipoto, their top four starters (Paxton, Hernandez, Iwakuma, and Tommy John candidate Drew Smyly) only contributed 17% of total innings pitched, just a tad below the 40% average. Finding adequate big league arms and compensating for injured aces (both current and former) will be tough. Still, getting a healthy, dominant Paxton back on the mound for 30+ starts would be a huge get for the team — whether or not the postseason is in their future next year.